Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.42 |
| ▸ | CTSK | P43235 | 3/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30688743 | 0.86 | MEN1 (0.44) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL21444905 | 0.86 | MEN1 (0.50) | MEN1GAAKMT2AFOLH1CTSK | |
| SCHEMBL47004 | 0.86 | FOLH1 (0.53) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL918952 | 0.86 | FOLH1 (0.53) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL376450 | 0.86 | FOLH1 (0.53) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL29581953 | 0.85 | MEN1 (0.52) | MEN1GAAKMT2AFOLH1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1711148 | 0.85 | FOLH1 (0.51) | SLC6A5MEN1GAAKMT2AITGB3 | |
| Hydrochloric Acid SCHEMBL28376761 | 0.85 | FOLH1 (0.51) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL6751878 | 0.85 | FOLH1 (0.51) | SLC6A5MEN1GAAKMT2AITGB3 | |
| SCHEMBL30395713 | 0.85 | FOLH1 (0.51) | SLC6A5MEN1GAAKMT2AITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118684726-A | Gly/Ser/Thr-Lys-Arg-Lys-gemcitabine, synthesis, activity and application thereof | 首都医科大学 | 2024-09-24 | — | — | CN | disclosed |
| CN-115466308-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-HGK, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-111793113-B | Synthesis, activity and application of dihydroxymethyl tetrahydrocarboline-3-formyl-The-HGK | 首都医科大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-112898376-B | Dioxane-modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, antitumor activity thereof and application thereof | 首都医科大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-112094322-B | His-Gly-Lys modified methotrexate, synthesis, antitumor activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-112979751-B | Dioxane-modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, anti-inflammatory activity thereof and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-112898380-B | Dioxohexa-ring modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, antithrombotic activity thereof and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-112094317-B | His-Gly-Lys modified methotrexate, synthesis, anti-transfer activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |